Delayed identification and diagnosis of Huntington's disease due to psychiatric symptoms

International Journal of Mental Health Systems

Volumn 9, Issue 1, 2015, Pages

  Pascu, Alina Mihaela ^a   Ifteni, Petru ^a,b   Teodorescu, Andreea ^b   Burtea, Victoria ^a   Correll, Christoph U ^c,d  

^a TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

^b Brasov University   (Romania)

^c Northwell Health   (United States)

^d DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGGRESSION; ARTICLE; CAG REPEAT; CASE REPORT; CONSCIOUSNESS DISORDER; DELAYED DIAGNOSIS; ELECTROENCEPHALOGRAM; FEMALE; GAIT DISORDER; GENE; GENETIC ANALYSIS; HTT GENE; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; PERSONALITY DISORDER; PRIORITY JOURNAL; RESTLESSNESS; SMOKING HABIT; SPEECH DISORDER; VERBAL HOSTILITY;

EID: 84939645332     PISSN: None     EISSN: 17524458     Source Type: Journal    
DOI: 10.1186/s13033-015-0026-6     Document Type: Article

References (18)

1. Gusella JF, Mac Donald ME. Huntington's disease: the case for genetic modifiers. Genome Med. 2009;1(8):80.
2. Novak MJ, Tabrizi SJ. Huntington's disease: clinical presentation and treatment. Int Rev Neurobiol. 2011;98:297-323.
3. Paulsen JS. Cognitive impairment in huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep. 2011;11:474-83.
4. Huntington Collaborative Research Group. A novel gene containing a trin- ucleotide that is expanded and unstable on huntington's disease chromosomes. Cell. 1993;72:971-83.
5. Walker FO. Huntington's disease. Lancet. 2007;369:218-28.
6. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311:864-8.
7. Craufurd D, Thompson JC, Snowden JS. Behavioral change in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:219-26.
8. Kingma EM, van Duijn E, Timman R, van der Mast RC, Roos RAC. Behavioral problems in Huntington's disease using the problem behaviors assessment. Gen Hosp Psychiatry. 2008;30:155-61.
9. Nopoulos PC, Aylward EH, Ross CA, et al. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain. 2011;134(Pt 1):137-42.
10. Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry. 2001;71(3):310-4.
11. Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord. 2012;27(9):1083-91.
12. Sitek EJ, Thompson JC, Craufurd D, Snowden JS. Unawareness of deficits in Huntington's disease. J Huntingtons Dis. 2014;3(2):125-35.
13. Zielonka D, Marinus J, De Roos RAC, Michele G, Di Donato S, Putter H, Marcinkowski J, Squitieri F, Bentivoglio AR, Landwehrmeyer GB. The influence of gender on phenotype and disease progression in patients with Huntington's disease. Parkinsonism Relat Disord. 2013;19(2):192-7.
14. Myers RH, Sax DS, Schoenfeld M, Bird ED, Wolf PA, Vonsattel JP, White RF, Martin JB. Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry. 1985;48(6):530-4.
15. Wheeler VC, Persichetti F, McNeil SM, Mysore JS, Mysore SS, MacDonald ME, Myers RH, Gusella JF, Wexler NS, US-Venezuela Collaborative Research Group. Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet. 2007;44(11):695-701.
16. Berrios GE, Wagle AC, Marková IS, Wagle SA, Ho LW, Rubinsztein DC, Whittaker J, Ffrench-Constant C, Kershaw A, Rosser A, Bak T, Hodges JR. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Res. 2001;102(3):217-25.
17. van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RA, van der Mast RCJ. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives. Clin Psychiatry. 2008;69(11):1804-10.
18. Smith JA, Michie S, Stephenson M, Quarrell O. Risk perception and decision-making processes in candidates for genetic testing for Huntington's disease: an interpretive phenomenological analysis. J Health Psychol. 2002;7(2):131-44.